Awarded with
1 CPD HOURS
Antibody-drug conjugates (ADCs) have reshaped the therapeutic approach to breast cancer, offering a more targeted means of delivering cytotoxic agents while reducing off-target effects. As their use becomes more widespread, particularly with agents like trastuzumab deruxtecan and sacituzumab govitecan, so does the need for healthcare professionals to understand their unique toxicity profiles and safety considerations. Effective monitoring and management of these side effects are essential to maximise therapeutic benefit and maintain patient quality of life. This CPD module equips clinicians with the knowledge to deliver evidence-based, patient-centred care when managing ADC-related toxicities.
This module features 10 clinical case-based multiple-choice questions (MCQs), each accompanied by detailed explanations and recommended reading to reinforce core concepts. Upon successful completion — achieving the minimum pass rate of 60% — you'll receive a downloadable 1-hour CPD certificate, suitable for printing or uploading to your annual CPD portfolio.
On completion of this CPD module, you will be able to:
Equip healthcare professionals with up-to-date knowledge on the toxicity profiles of ADCs used in breast cancer and the strategies for early identification and mitigation of adverse effects.
Emphasise the importance of a patient-centred approach in optimising the quality of life for individuals receiving ADC therapy.
Foster interdisciplinary communication and practice improvements that support the safe, effective, and compassionate use of ADCs.
Identify common and serious toxicities associated with breast cancer ADCs and understand their underlying mechanisms.
Implement early detection, risk stratification, and intervention strategies to minimise treatment-related morbidity.
Apply holistic patient-centred care approaches to support psychological wellbeing, functional status, and quality of life during and after ADC therapy.
Meet the author who developed our Optimising Safety and Quality of Life of the Patients Treated for Breast Cancer With Antibody-Drug Conjugates CPD Module. Our entire faculty have the right experience, qualifications and expertise that make them the perfect candidates to write high-quality, relevant material for our secondary care CPD modules..
Available all year round with 24/7 online access and unlimited resits, you'll be able to learn around your busy schedule and get to grips with your CPD modules whenever you'd like - all you need is an internet connection.
Our CPD modules are written and edited by medical experts within their specialist fields, who have pedigrees in postgraduate education. Questions are reviewed regularly to ensure that they remain relevant and up-to-date with new guidelines.
As a healthcare professional, it's important for you to continuously expand on your clinical knowledge, skills and abilities. Our CPD modules will help you achieve this by providing you with a full explanation of answers, further reading, and the option to reflect using our online notes system.